Type 1 Diabetes Complication Screening — Book Blood Tests at Home

ADA recommends HbA1c every 3 months, annual lipid panel, annual urine albumin-to-creatinine ratio (ACR) and eGFR for kidney function, periodic TSH for thyroid, and celiac screening at diagnosis. Additional tests include fasting blood glucose, C-peptide, vitamin B12, and comprehensive metabolic panels depending on your complications profile.

Type 1 Diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells in the pancreas. Unlike Type 2, it is not caused by lifestyle factors and requires lifelong insulin therapy. T1D patients also have significantly higher risk of autoimmune comorbidities like thyroid disease (15-30%) and celiac disease (4-9%).

HbA1c (glycated hemoglobin) measures your average blood sugar over the past 2-3 months. For T1D patients, ADA recommends a target below 7% for most adults. Each 1% reduction in HbA1c lowers microvascular complication risk by approximately 37%. Testing every 3 months helps track long-term glycemic control.

Yes. Diabetic nephropathy is the leading cause of end-stage renal disease worldwide. ADA recommends annual screening with urine albumin and eGFR after 5 years of T1D diagnosis or from age 11. Early detection through microalbumin testing allows intervention that can reverse early kidney damage.

T1D patients have a 15-30% lifetime risk of developing autoimmune thyroid disease (Hashimoto's or Graves'). ADA recommends TSH screening at T1D diagnosis and every 1-2 years thereafter. Undiagnosed thyroid dysfunction can worsen glycemic control and cause fatigue, weight changes, and other symptoms.

Diabetic neuropathy is nerve damage caused by prolonged high blood sugar. It can be peripheral (tingling, numbness in hands/feet) or autonomic (affecting digestion, heart rate, bladder). ADA recommends annual screening with a comprehensive foot exam. Blood tests like Vitamin B12 can identify deficiencies that worsen neuropathy.

Yes. Truemark Health offers home sample collection for all T1D-related blood tests including HbA1c, kidney function tests (KFT), lipid panel, thyroid profile (TSH, T3, T4), celiac markers, and comprehensive metabolic panels. We operate across 100+ cities in India with NABL-certified partner labs.

No. This screening tool is for informational purposes only and is designed to help you identify potential gaps in your T1D complication monitoring. It does not constitute medical advice, diagnosis, or treatment. Always consult your endocrinologist or healthcare provider for personalized diabetes management decisions.